BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 5883465)

  • 1. Sensitivity of different phases in the cell cycle of ascites tumor cells under the influence of cyclophosphamide.
    Palme G; Liss E
    Antimicrob Agents Chemother (Bethesda); 1965; 5():497-502. PubMed ID: 5883465
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of cyclophosphamide on Ehrlich ascites cells.
    Liss E; Palme G
    Antimicrob Agents Chemother (Bethesda); 1965; 5():493-6. PubMed ID: 5883464
    [No Abstract]   [Full Text] [Related]  

  • 3. Different uptake of two alkylating substances by ascites tumor cells.
    Schmidt H; Liss E
    Arzneimittelforschung; 1978; 28(11):2150-2. PubMed ID: 582920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of the carcinostatic agents on the cell cycle of Ehrlich ascites carcinoma cells.
    Kin T
    Nagoya J Med Sci; 1971 Mar; 33(4):307-14. PubMed ID: 5554416
    [No Abstract]   [Full Text] [Related]  

  • 5. [The time dependent, electronically measured change in volume frequency distribution of Ehrlich ascites tumor cells after treatment with alkylating cytostatics in vivo].
    Gutsche W
    Arzneimittelforschung; 1971 Apr; 21(4):444-6. PubMed ID: 5108137
    [No Abstract]   [Full Text] [Related]  

  • 6. Reduction of hematotoxicity and augmentation of antitumor efficacy of cyclophosphamide by dopamine.
    Lakshmi C; Deb C; Ray C; Ray MR
    Neoplasma; 2005; 52(1):68-73. PubMed ID: 15739030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of combined treatment using ionising rays and cyclophosphamide on the mitotic rate of Ehrlich ascites tumors].
    Kaufmann H; Harder S
    Strahlentherapie; 1971 Dec; 142(6):677-80. PubMed ID: 5153125
    [No Abstract]   [Full Text] [Related]  

  • 8. [Autoradiographic and histochemical studies of the effect of verrucarin I on the cells of Ehrlich ascites tumor in different phases of the cell cycle].
    Wiatr Z
    Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1984-1985; 29-30():95-106. PubMed ID: 6443829
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of cyclophosphamide on tumor cell sensitivity to the action of immunological effectors.
    Culo F; Marić M; Morović-Vergles J
    In Vivo; 1995; 9(5):439-46. PubMed ID: 8900921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoprotection and enhancement of cancer chemotherapeutic efficacy of cyclophosphamide in mice bearing Ehrlich ascites carcinoma by diphenylmethyl selenocyanate.
    Chakraborty P; Sk UH; Bhattacharya S
    Cancer Chemother Pharmacol; 2009 Oct; 64(5):971-80. PubMed ID: 19221751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in various biochemical indices and ultrastructure of ascites tumors after combined administration of cyclophosphamide and levorin].
    Oksman AIa; Lisochkin BG; Marikhina BL; Eremeeva AA
    Eksp Onkol; 1984; 6(1):57-61. PubMed ID: 6499734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlations between the chemical structure of Mannich bases with and without nitrogen mustard groups and their cytostatic effect on Ehrlich ascites carcinoma in albino mice].
    Werner W; Jungstand W; Gutsche W
    Arzneimittelforschung; 1970 Feb; 20(2):246-9. PubMed ID: 5467470
    [No Abstract]   [Full Text] [Related]  

  • 13. Dual effects of indoleamine 2,3-dioxygenase inhibitors on the therapeutic effects of cyclophosphamide and cycloplatam on Ehrlich ascites tumor in mice.
    Bogdanova LA; Morozkova TS; Amitina SA; Mazhukin DG; Nikolin VP; Popova NA; Kaledin VI
    Bull Exp Biol Med; 2014 Aug; 157(4):506-9. PubMed ID: 25110094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of single and combined treatments on Ehrlich ascites tumor in mice].
    Mekori T; Robinson E
    Harefuah; 1971 Feb; 80(3):123-5. PubMed ID: 4999821
    [No Abstract]   [Full Text] [Related]  

  • 15. Anticancer activity of alkylating agents derived from various diamines and diols on Ehrlich Ascites carcinoma.
    Skinner WA; Scholler J
    Cancer Chemother Rep; 1967 Aug; 51(4):205-11. PubMed ID: 5623729
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of hyperbaric oxygenation on the anticancer effect of alkylating agents (endoxan and mitomycin-C).
    Miyamoto Y
    Kumamoto Med J; 1968 Sep; 21(3):108-13. PubMed ID: 5708370
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the leukocyte reaction in Ehrlich's ascites tumor and its changes induced with panirradiation and pretreatment with cyclophosphamide].
    Piccotti F; Ballaira L; Isoardi Pons A; Cirillo R
    Riv Crit Clin Med; 1968; 68():Suppl 6:966+. PubMed ID: 5747768
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of an alkylating agent on liver arginase in normal and Ehrlich carcinoma bearing mice.
    Abreu RR; Abreu LA
    Hospital (Rio J); 1969 Jul; 76(1):345-51. PubMed ID: 5307536
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of nitidine chloride on the life cycle of Ehrlich ascites carcinoma cells in mice (author's transl)].
    Fan YJ; Zhou J; Li M
    Zhongguo Yao Li Xue Bao; 1981 Mar; 2(1):46-9. PubMed ID: 6461202
    [No Abstract]   [Full Text] [Related]  

  • 20. [Micronuclear and antitumor activities of two newly synthesized pyrimidine derivatives].
    Nersesian AK; Muradian RE; Arsenian FG
    Tsitologiia; 2008; 50(1):79-82. PubMed ID: 18409373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.